Page last updated: 2024-11-07

penicillamine and Uremia

penicillamine has been researched along with Uremia in 3 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kokot, F1
Asahi, K1
Ichimori, K1
Nakazawa, H1
Izuhara, Y1
Inagi, R1
Watanabe, T1
Miyata, T1
Kurokawa, K1
Seegmiller, JE1
Friedmann, T1
Harrison, HE1
Wong, V1
Schneider, JA1

Other Studies

3 other studies available for penicillamine and Uremia

ArticleYear
[Use of immunosuppresive agents in the treatment of kidney diseases. Drug therapy of uremia and kidney calculi].
    Przeglad lekarski, 1982, Volume: 39, Issue:7

    Topics: Allopurinol; Azathioprine; Benzothiadiazines; Cyclophosphamide; Diuretics; Glucocorticoids; Humans;

1982
Nitric oxide inhibits the formation of advanced glycation end products.
    Kidney international, 2000, Volume: 58, Issue:4

    Topics: Adult; Arginine; Carbonates; Cross-Linking Reagents; Female; Free Radical Scavengers; Glycation End

2000
Cystinosis. Combined clinical staff conference at the National Institutes of Health.
    Annals of internal medicine, 1968, Volume: 68, Issue:4

    Topics: Amino Acid Metabolism, Inborn Errors; Biopsy; Bone Marrow; Child; Chronic Kidney Disease-Mineral and

1968